MedPath

Barco Nv

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Development and Validation of a New Digital Dermatoscope in the United States

Completed
Conditions
Skin Cancer
First Posted Date
2019-08-06
Last Posted Date
2020-06-18
Lead Sponsor
Barco NV
Target Recruit Count
60
Registration Number
NCT04047316
Locations
🇺🇸

Dermatologic Surgery Center of Washington LLC, Chevy Chase, Maryland, United States

🇺🇸

Silver Falls Dermatology, Salem, Oregon, United States

Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer

Active, not recruiting
Conditions
Skin Diseases
Skin Cancer
First Posted Date
2019-01-28
Last Posted Date
2025-02-05
Lead Sponsor
Barco NV
Target Recruit Count
3000
Registration Number
NCT03818620
Locations
🇧🇪

UZ Gent, Gent, Belgium

🇧🇪

UZ / KU Leuven, Leuven, Belgium

Utility of Digital Dermoscopy in the Skin Cancer Clinic

Terminated
Conditions
Skin Cancer
Dermatology/Skin - Other
First Posted Date
2018-04-13
Last Posted Date
2021-12-29
Lead Sponsor
Barco NV
Target Recruit Count
13
Registration Number
NCT03497455
Locations
🇬🇧

Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

News

PathPresenter Receives FDA 510(k) Clearance for Digital Pathology Clinical Viewer

PathPresenter has received FDA 510(k) clearance for its Clinical Viewer platform, enabling primary diagnosis using digital pathology workflows.

© Copyright 2025. All Rights Reserved by MedPath